Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment: a Prospective, Multicentric, Cohort Study (RAISE)

NCT06409832 is registered in ClinicalTrials.gov with University of Florence as lead sponsor.

NCT NCT06409832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06409832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment: a Prospective, Multicentric, Cohort Study (RAISE)
Lead sponsor
University of Florence
Phase
Observational
Overall status
Recruiting
Start date
March 26, 2024
Completion date
September 30, 2027
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, migraine with aura, migraine without aura